UNITY Biotechnology’s $45 Million Shares Offering

Laura Testa North America Legal Chronicle
Tagged:

Latham & Watkins represented UNITY Biotechnology in the transaction.UNITY Biotechnology, Inc. (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, has announced…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here